Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review

被引：0

作者：

Sood, Siddhartha ^{[1
]}

Bagit, Ahmed ^{[1
,2
]}

Heung, Martin ^{[3
]}

Maliyar, Khalad

Abduelmula, Abrabim ^{[3
]}

Sachdeva, Muskaan ^{[3
]}

Georgakopoulos, Jorge R. ^{[3
]}

Mufti, Asfandyar ^{[3
,4
]}

Prajapati, Vimal H. ^{[5
,6
,7
,8
,9
,10
]}

Yeung, Jensen ^{[3
,4
,10
,11
]}

机构：

[1] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada

[2] McMaster Univ, Fac Hlth Sci, Hamilton, ON, Canada

[3] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada

[4] Sunnybrook Hlth Sci Ctr, Dept Dermatol, Toronto, ON, Canada

[5] Univ Calgary, Dept Med, Div Dermatol, Calgary, AB, Canada

[6] Dermatol Res Inst, Calgary, AB, Canada

[7] Skin Hlth & Wellness Ctr, Calgary, AB, Canada

[8] Univ Calgary, Dept Pediat, Sect Community Pediat, Calgary, AB, Canada

[9] Univ Calgary, Dept Pediat, Sect Pediat Rheumatol, Calgary, AB, Canada

[10] Prob Med Res, Waterloo, ON, Canada

[11] Womens Coll Hosp, Dept Dermatol, 76 Grenville St,5th floor, Toronto, ON M5S 1B2, Canada

来源：

JAAD INTERNATIONAL | 2024年 / 16卷

关键词：

abrocitinib; atopic dermatitis; bariciti-; nib; dupilumab; evidence-based; Janus kinase inhibitor; systematic review; upadacitinib;

D O I：

10.1016/j.jdin.2024.03.023

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：31 / 33

页数：3

共 50 条

[1] Switching to systemic janus kinase inhibitors following dupilumab failure for atopic dermatitis: an evidence-based review
Sood, S.
Bagit, A.
Heung, M.
Maliyar, K.
Abduelmula, A.
Sachdeva, M.
Georgakopoulos, J.
Mufti, A.
Prajapati, V.
Yeung, J.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S339 - S339
[2] The Use of Janus Kinase Inhibitors for Lichen Planus: An Evidence-Based Review
Abduelmula, Abrahim
Bagit, Ahmed
Mufti, Asfandyar
Yeung, Katie C. Y.
Yeung, Jensen
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2023, 27 (03) : 271 - 276
[3] Use of Janus kinase inhibitors in atopic dermatitis - an update
Dhar, Sandipan
Datta, Shreya
De, Abhishek
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2024, 90 (03): : 311 - 317
[4] Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
Eshtiaghi, Panteha
Gooderham, Melinda J.
CORE EVIDENCE, 2018, 13 : 13 - 20
[5] Safety considerations of systemic Janus kinase inhibitors in atopic dermatitis applications
Chang, Po-Hsiung
Huang, Sheng-Fen
Chang, Po-Sheng
Yu, Yu
JOURNAL OF DERMATOLOGY, 2021, 48 (11): : 1631 - 1639
[6] Management of Chronic Prurigo and Prurigo Nodularis with Systemic Janus Kinase Inhibitors: An Evidence-Based Review
Sood, Siddhartha
Geng, Ryan S. Q.
Heung, Martin
Maliyar, Khalad
Abduelmula, Abrahim
Sachdeva, Muskaan
Georgakopoulos, Jorge R.
Mufti, Asfandyar
Prajapati, Vimal H.
Yeung, Jensen
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2025,
[7] The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis
Carlos Alves
Ana Penedones
Diogo Mendes
Francisco Batel Marques
European Journal of Clinical Pharmacology, 2022, 78 : 1923 - 1933
[8] The safety of systemic Janus kinase inhibitors in atopic dermatitis: a systematic review and network meta-analysis
Alves, Carlos
Penedones, Ana
Mendes, Diogo
Marques, Francisco Batel
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (12) : 1923 - 1933
[9] Systemic Janus kinase inhibitor treatment for vitiligo: An evidence-based review
Sood, Siddhartha
Varenbut, Jaymie
Bagit, Ahmed
Perlmutter, Jonah
Maliyar, Khalad
Sachdeva, Muskaan
Abduelmula, Abrahim
Georgakopoulos, Jorge R.
Mufti, Asfandyar
Prajapati, Vimal H.
Yeung, Jensen
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (01) : 135 - 137
[10] Cardiovascular comorbidities in atopic dermatitis: Potential implications for the use of Janus kinase inhibitors
Jackson, J. Mark
Althoff, Amanda
Rasouliyan, Lawrence
Long, Stacey
Zema, Carla L.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (06) : 1296 - 1298

← 1 2 3 4 5 →